Fig. 3: Distribution of ESRRA genetic alterations in triple-negative invasive lobular carcinoma compared to two control groups. | Modern Pathology

Fig. 3: Distribution of ESRRA genetic alterations in triple-negative invasive lobular carcinoma compared to two control groups.

From: Triple-negative breast lobular carcinoma: a luminal androgen receptor carcinoma with specific ESRRA mutations

Fig. 3

The location of alterations identified by whole-exome sequencing in different regions of the gene is shown. The bar heights are proportionate to the number of mutant cases (n). TN-ILC triple-negative invasive lobular carcinoma, TN-IDC triple-negative invasive ductal carcinoma, HR + ILC hormone receptor-positive invasive lobular carcinoma.

Back to article page